1. Introductionenvironmentclearance.nic.in/writereaddata/Online/... · “SKPL or Industry”) is...
Transcript of 1. Introductionenvironmentclearance.nic.in/writereaddata/Online/... · “SKPL or Industry”) is...
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
1
1. Introduction
M/s. Sri Krishna Pharmaceuticals Limited. (herein after referred to as
“SKPL or Industry”) is located at IDA, Bollaram, Medak District in Andhra
Pradesh. The unit was established in 1986 under the name of Arandy
Laboratories Limited and current management had taken over the unit in
2005.
M/s. Sri Krishna Pharmaceuticals Limited obtained Environmental
Clearance from MOEF Post Ex facto vide Order No J-11011/170/2005-
IA.II(I), Dt: 11.08.2005. to manufacture Fusemide with 5 TPM and
Glibenclamide with a capacity of 1.0 TPM
Subsequently unit obtained CFE of the Board and CFO vide Obtained
Consent for Operation vide letter no: APPCB/PTN/BLM/287/HO/2012-
dated 11.10.2012 to manufacture 3 Drugswith a combined capacity of 6
TPM. In order to meet the market demand now Sri Krishna
Pharmaceuticals Limited, unit IVproposed to expand the production
Capacity from 6 TPM to 40 TPM
A copy of the environmental clearance obtained from MOEF, Government
of India in 2005 and certified copy of compliance report obtained MOEF,
Government of India, and Bangalore Regional office is enclosed at
Annexure I
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
2
2. Introduction of the Project / Background Information:
The salient features of the project are described in table below
TABLE 1.0
Salient Features of the Project
Location Sy. No 267/7/10,IDA Bollaram,
Jinnaram(M), Medak District, Andhra Pradesh
Longitude and latitude 17°32'43.7"N Latitude and 78°20'10.4"East Longitude.
Year of establishment 1986
Product category 5(F) Bulk Drugs & Intermediates
Project category as per EIA notification
Category B ( Located in notified industrial Estate
Proposed Activity Capacity expansion from 6 TPM to 40TPM
Total investment on the plant Current - Rs. 13.50& Proposed – Rs.89Crores
Total Investment on Environmental Infrastructure
Current - Rs. 2.0 Crores Proposed - Rs. 10.5 Crore Total 12.50
Total area of the plant 4.5 Acres (18,211 Square meters)
Total area of green belt 6760 Square meters
Water requirement Fresh water requirement – 396.00
KLD
Source of water Purchased from local sources
Nearest habitation and distance from the site
Bollaram (V) at a distance of 1.0 KM of the site
Nearest surface water bodies Except rain fed tanks there is no major surface water body in the study area
Nearest reserve forest 9 Reserve forests in the study area
Environmentally sensitive areas within 10 km radius
None
Any national parks, wild life sanctuaries within 10 km radius
None
Nearest air port and distance Samshabad50 KM
Nearest railway station and
distance
Lingampally 7.5 KM
Industrial Estates/Clusters in 10 KM radius
Khazipalli, Patancheru, RC Puram
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
3
i) About the Group & Promoters
Sri Krishna Pharmaceuticals Limited, established in the year 1975 under
the companies act 1956, manufacturing bulk drugs and intermediates
(APIs) started its operation in A.P with its first unit in IDA Uppalto
manufacture Paracetamol. Subsequent to this , group has established a
formulation unit at IDA Nacharam in 2004, bulk drugs manufacturing unit
in Raikunta village, Shamshabad (Mandal) RR Dist , a Bulk Drug
Manufacturing unit at Plot No. B-14, MIDC, Chincholi in Solapur in the
year 2008.
It had taken over the company named M/s Arandy Laboratories Limited,
IDA Bollaram, Medak Dist and amalgamated in to Sri Krishna group as
unit-IV .
Sri Krishna Group is emerged as major supplier of API’s internationally
through it’s efforts in quality and reliability. It is currently catering to the
needs of the domestic customers and customers in Europe, US, Germany,
Japan and Latin America.
The group is adopting cleaner environment technologies and complying to
the directions issued by APPCB from time to time. The industry made and
continuously making all efforts to treat liquid solid & Air to achieve
standards prescribed. Upgrading the facilities time to time as per the
technologies available.
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
4
3. Project Description
3.1 Production Capacity:
Currently the unit is permitted to manufacture 3 drugs with a total
capacity of 6 TPM as detailed below
TABLE 2.0
LIST OF EXISTING PRODUCTS & CAPACITY
S.No Name of the Product Quantities in
Kg/day
1. Frusemide 133.33
2 Glibenclamide 33.33
3 Glipizide 33.33
Total 199.99
3.1.1 Proposed Products & Capacity:
It is now proposed to expand the production capacity of the existing 3
products. Below Table provides list of products and proposed capacities.
TABLE 3.0
PROPOSED PRODUCTS & CAPACITY
S.No Product Name
Productio
n Capacity
TPM
Product Description
Drug/Intermediate/Multipurp
ose chemicals
1 Frusemide 15.0 Bulk Drug
2 Glibenclamide 5.0 Bulk Drug
3 Glipizide 5.0 Bulk Drug
4 Levostatin 15.0 Bulk drug
Total 40.00
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
5
3.2 Manufacturing Process
The detailed manufacturing process and process flow sheets are enclosed
at Annexure III
3.3 Raw Materials
List of raw material used product wise is give at Annexure II
3.4 Water Requirement
The water requirement is met from local suppliers through tankers. The
requirement for water in this unit is for process and domestic purposes.
The water balance for daily consumption is presented below.
TABLE 4.0
Water Balance– Current & Proposed
S. No
Stream
Water requirement in KLD
Waste Water discharge in KLD
Proposed Method of
Treatment
and Disposal
Current After Expansion
Current After Expansion
1
Process
15.00
190
15.53
205
Stripper,
MEE and ATFD (
Condensate to RO)
2
Washings 10.0 10.0
Stripper,
MEE and ATFD (
Condensate to RO)
3
Boiler 42.0 69.0 6.97 7.0
ETP followed by
RO ( Ro Reject to
MEE)
4 Cooling
tower
30 150 12.0
ETP
followed by
RO ( Ro
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
6
Reject to
MEE)
5
Domestic 4.0 15.0 3.0 10.0
ETP
followed by
RO ( Ro
Reject to
MEE)
6
Gardening 7.0 7.0 ----- --
ETP
followed by
RO ( Ro
Reject to
MEE)
Total 98.0 441.0 25.5 244.0
3.5 Wastes generation and control systems
3.5.1 Liquid Effluents
As detailed in table4.0 waste water generation after expansion would be
244 KLD. It is proposed to segregate effluents into high COD and High
TDS stream and Low COD and Low TDS streams
High TDS and High COD stream would be treated in stripper followed by
MEE and ATFD. The resultant sludge would be disposed to TSDF,
Hyderabad. The Low TDS stream would be treated along with MEE/ATFD
condensates in biological ETP followed by RO. The RO rejects would be fed
back to MEE. The Permeate from RO would be used for cooling tower
make up. Thus the treatment system proposed is based on “Zero Liquid
Discharge” (ZLD) Concept
The schematic diagrams of ETP proposed are given in Figure 1.1 and
Figure 1.2 below
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
7
Fig 1.1 Schematic treatment scheme of high TDS effluents
Effluent from Process and Aq. Distillate to cement plant/
Authorized recyclers washings , Scrubber
R&D RO Reject To TSDF Condensate to Biological Treatment Condensate to Biological Treatment
Sludge to TSDF
Stripper Setting
Tank
Neutralization
Tank
Equalization
Tank
MEE
ATFD
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
8
Fig 1.2 Low TDS Effluent Treatment System
Domestic effluent
Effluents from utilities & MEE condensate
Sludge to TSDF
Permeate for re-use
Rejects to MEE
Screen
Chamber
Sludge Holding Tank
Aeration
Tank2
Equalization
Tank
Neutralization
Tank
Clarifier
2
Holding
Tank
Filter Press Sludge Cake
Aeration
Tank1 Clarifier
1
Sand
filter
Carbon
Filter
Ultra
filtration RO
Screen
Chamber
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
9
3.5.2 Solid wastes management
Hazardous and non-hazardous wastes generated from the proposed
expansion project are detailed below. Mode of disposal are also identified
and listed. Adequate storage of hazardous waste is ensured at the site.
TABLE 5.0
Solid Wastes and Disposal
S.No
Description
Quantity TPM
Remarks Current After
Expansion
1 ETP Sludge (gypsum)
6.073 21.59 Sent to Cement industry
2 FE Salts 8.908 92.89 Sent to TSDF
3 Distillation
bottom residue
2.372 29.10 Sent to TSDF / Authorized
cement industries for Co-Processing
4 Spent Carbon 0.878 3.384 Sent to TSDF / Authorized
cement industries for Co-Processing
5 Inorganic
residue
0 246.9 Sent to TSDF
TOTAL 18.231 393.86
Wastes with recyclable option
6 Used Oil 1600 LPM 1600 LPM Authorized Re-processors
/Recyclers
7 De-toxified container &
container liners
80 Nos/Month
150 Nos/Month
After detoxification, disposed to outside agencies
8 Spent
solvents
48 KL/
month(as
per CFO)
250KL/
month
Recovery within the
premises, & Re use, residue to TSDF
47
KL/Month
Dispose to authorized
recyclers
9 Ash from
Boilers
10.0 TPM 50.0 TPM Sold to Brick Manufacturers
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
10
TSDF facility is about 18 KM from the site in Ranga Reddy District which is
created for catering the industries in this area. Transport of Hazardous
wastes to TSDF is done by the facility. In case other hazardous wastes,
authorized recyclers will transport the wastes
4. Site Analysis
4.1 Plant Location
M/s Sri Krishna Pharmaceuticals Limited, Unit- IV is located at Survey
No.267/7/10 of Bollaram(V), Jinnaram(M), Medak District, Andhra
Pradesh.The site is situated at 17°32'43.7"N Latitude and 78°20'10.4"
East Longitude. The land area of the plant is 4.5 acres. The nearest
habitation from the site is Bollaram (V) at a distance of 1.0 km. The
nearest railway station is located at Lingampally at a distance of 7.5Km
from the site. There are no ecologically sensitive areas like national parks,
sanctuaries within 10 km radius of the site.
The site is surrounded by other industries of IDA Bollaram Open plot on
the Southern side, Public Road on the north side are located .Industries
are located on the Eastern and western side of the site.
Following 9 reserve Forests are there within 10 KM radius of the site
Table 6.0
Reserve Forests in the study area
S.No Reserve Forest Direction from the
site
Distance from the
site
1 Kodananchi NW 7.5 KM
2 Pottaguda NW 6.9 KM
3 Wailal N 5.7 KM
4 Kazipalli NE 3.17 KM
5 Dundigal NE 6.2 KM
6 Gajularamamram W 7.5 KM
7 Borampet W 7.14 KM
8 Suraram W 8.6 KM
9 Kothaguda S 9.2 KM
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
11
Topo graphic features of the site and 10 KM study area and base map are
given at Fig 1.3 & 1.4.
Plant Photographs are given at Fig. 1.5
Site lay out map is given at Fig 1.6
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
12
Fig 1.3
Topo Sheet of the 10 KM study area
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
13
Fig 1.4
Base map of the study area
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
14
Fig 1.5
Plant Lay out
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
15
Fig 1.6
Plant Photographs
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
16
5. Planning in Brief
The project is envisaged to be completed by Feb 2015, and the enhanced
production shall be initiated thereon. Consultants are identified for
preparing the detailed project report.
6. Resource requirements
6.1 Power Requirement and Supply/Source
The total power requirement is 2000 KVA. It shall be sourced from
APCDDL and D.G sets as alternative to Power failure.
6.2 Production facilities, Utilities and effluent handling facilities
Apart from the existing facilities it is proposed to add additional
production facilities, utilities and effluents treatment infrastructure with
an additional investment of Rs. 89 Cores. The details are outlined in the
below table
TABLE 7.0
Production facilities/Utilities/ETP – Existing & Proposed
S.NO Details
Capacity/
No Current
Additions
After
expansion
Production facilities
1 Production Blocks- Nos 3 2 5
2 Clean rooms Nos 1 3 4
Utilities
3 Boiler ( coal Fired) TPH 3 10 13
4 DG sets KVA 360
(1X 360)
1000
(2x 500 KVA)
1360
5 Cooling tower TR 910
(1x200,1x250, 1x300,1x160
2000
4x500
2910
6 Softner/DM plant M3/hour 2.5 5.0 7.50
Effluent handling & treatment facilities
7 collection tanks-
Storage
KL 120 950 1070
8 Neutralisation tanks KL 1 2 3
9 Stripper ,MEE,ATFD KLD 50 200 250
10 RO & Biological treatment
KLD 0 250 250
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
17
6.3 Land Requirement
The unit currently has 4.5 acres of land and out of which 1.6 acres of
green belt is developed. The land requirement for proposed expansion
activities will be 5000 Square Meters which can be met from existing open
area. Below table provides the land statement. Detailed site lay out plan
outlining current and proposed expansion activities is given at Figure 1.5
Table 8.0 Land Statement
S.NO Purpose Units Extent
1 Built up area Sq.M 3357
2 Green belt Sq.M 6760
3 Open area Sq.M 8094
Total Sq.M 18211
4 Area required for Proposed
expansion
Sq M 5000
7.0 Air Pollution
The Sources of air emissions from the plant are 1x 3 TPH coal fired boiler
& proposed 1 × 10 TPH coal fired boiler and additional DG sets
The process emissions from the process are Ammonia and HCl and are
scrubbed with caustic and scrubbed waste send to MEE. The other gases
expected in the process are Carbon dioxide, which are let out into
atmosphere Below Table gives current proposed emission sources from
the plant
Table 9.0 Emission Source – Current & Proposed
S.NO Source Capacity
Fuel Anticipated emissions
Control system
Current
1 Boiler 3 TPH Coal SPM,SO2 & NOx
Cyclone separator
2 DG sets 1x360 Diesel SPM, SO2, Acoustic
Pre-Feasibility Report Sri Krishna Pharmaceuticals Limited, Unit IV
18
KVA NOX enclosure
3 Process emissions -- -- Ammonia
and HCl
Scrubber
Proposed additions
4 Boiler ( coal Fired) 10 TPH Coal SPM,SO2 & NOx
Bag filter
5 DG sets 2x500 KVA
Diesel SPM, SO2 & NOx
Acoustic Enclosure
6 Process emissions -- -- Ammonia
and HCl
Scrubber
8. Project Financial
The estimated cost of the expansion project is approximately 89.0Crores.
Out of this Rs. 10.50Crores will be for effluents treatment facilities and
rest for other process equipment and safety equipment
Project cost
Rs. In lakhs
Plant& machinery 50
Civil & structural 5
Total 55
Pipe lines & insulation 20% on plant & machinery 11
Electricals & instrumentation 10% on plant & machinery 5.5
Erection & commissioning & painting
8% on plant &
machinery and structures 4.4
Safety & Environment 10.50
Furniture, fixtures, computers,
lighting etc 0.50
Total 86.90
Contingencies & pre-operative
expenses 2.0
Project cost 88.90
Say Rs.89 Crores